Michael S Rogers Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

4/2002

S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael S Rogers Research Topics

Disease

6	Neoplasms (Cancer) 09/2012 - 04/2002
4	Corneal Neovascularization 01/2014 - 07/2009
3	Pain (Aches) 01/2023 - 01/2020
2	Arthritis (Polyarthritis) 01/2023 - 01/2012
2	Lung Diseases (Lung Disease) 11/2018 - 01/2018
2	Choroidal Neovascularization 01/2014 - 07/2009
2	Retinal Diseases 09/2012 - 01/2011
2	Anthrax 01/2012 - 01/2011
2	Multiple Myeloma 06/2006 - 04/2002
1	COVID-19 04/2023
1	Hyperalgesia 01/2023
1	Inflammation (Inflammations) 01/2023
1	Edema (Dropsy) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 10/2022
1	Gout 01/2022
1	Gouty Arthritis 01/2022
1	Pathologic Neovascularization 01/2022
1	Endometriosis 01/2020
1	Chronic Pain 01/2020
1	Mental Disorders (Mental Disorder) 12/2019
1	Congenital Diaphragmatic Hernias 11/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Retinal Vein Occlusion 01/2014
1	Oculocutaneous albinism type 2 01/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2012
1	Blindness (Hysterical Blindness) 07/2009
1	Birth Weight (Birth Weights) 05/2008
1	Hypoglycemia (Reactive Hypoglycemia) 05/2008
1	Gestational Diabetes (Gestational Diabetes Mellitus) 09/2007
1	Diabetes Mellitus 09/2007
1	Glucose Intolerance 09/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2007
1	Pre-Eclampsia (Preeclampsia) 01/2007
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2004
1	Hematologic Neoplasms (Hematological Malignancy) 04/2002
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2002
1	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2002

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2007
4	anthrax toxin (anthrax lethal factor)IBA 01/2022 - 10/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 07/2009
2	Analgesics (Analgesic Drugs)IBA 01/2023 - 01/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014 - 11/2003
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2009 - 07/2004
2	Glucose (Dextrose)FDA LinkGeneric 05/2008 - 09/2007
2	Thalidomide (Thalomid)FDA Link 06/2006 - 04/2002
1	VaccinesIBA 04/2023
1	Transient Receptor Potential ChannelsIBA 01/2023
1	lipoxin A4IBA 01/2023
1	LipoxinsIBA 01/2023
1	titanium dioxide (Titania)FDA Link 01/2023
1	Uric Acid (Urate)IBA 01/2022
1	Letrozole (Femara)FDA LinkGeneric 01/2020
1	Danazol (Azol)FDA LinkGeneric 01/2020
1	Aromatase InhibitorsIBA 01/2020
1	AndrogensIBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	serum P-component (CIt)IBA 12/2019
1	Heparin (Liquaemin)FDA LinkGeneric 11/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	matrigelIBA 01/2014
1	Cell Surface ReceptorsIBA 01/2012
1	anthrax toxin receptorsIBA 01/2011
1	C-PeptideIBA 05/2008
1	AntigensIBA 10/2007
1	FicolinsIBA 01/2007
1	CytokinesIBA 01/2007
1	polyacrylamideIBA 01/2007
1	3-aminophthalimidoglutarimideIBA 04/2002
1	glutarimideIBA 04/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2011
3	Lasers (Laser) 01/2014 - 01/2007
1	Prostheses and Implants (Prosthesis) 01/2023
1	Extracorporeal Membrane Oxygenation 11/2018